MELANIE BOGGS: Open Payments
NPI 1740241603 · GLEN ALLEN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,579 in 81 payments from 20 companies in 2025. Trend: 2023 $1,223 · 2024 $1,362 · 2025 $1,579
Food & beverage: $1,579
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $277 |
| Amgen Inc. | 10 | $159 |
| ABBVIE INC. | 14 | $152 |
| PFIZER INC. | 9 | $150 |
| Novo Nordisk Inc | 7 | $146 |
| Phathom Pharmaceuticals, Inc. | 2 | $138 |
| Merck Sharp & Dohme LLC | 4 | $75 |
| Abbott Laboratories | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Lilly USA, LLC | 3 | $59 |
Products named: VOQUEZNA, AIRSUPRA, NURTEC ODT, Ozempic, EVENITY, FARXIGA, UBRELVY, GARDASIL 9.
Industry payments across VA — which companies pay providers there.
